SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
1.835
-0.033 (-1.77%)
Jun 5, 2025, 4:00 PM - Market closed
SAB Biotherapeutics Market Cap
SAB Biotherapeutics has a market cap or net worth of $17.05 million as of June 5, 2025. Its market cap has decreased by -46.45% in one year.
Market Cap
17.05M
Enterprise Value
10.98M
1-Year Change
-46.45%
Ranking
Category
Stock Price
$1.83
Market Cap Chart
Since February 9, 2021, SAB Biotherapeutics's market cap has decreased from $130.75M to $17.05M, a decrease of -86.96%. That is a compound annual growth rate of -37.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2025 | 17.05M | -51.31% |
| Dec 31, 2024 | 35.02M | -44.79% |
| Dec 29, 2023 | 63.43M | 113.36% |
| Dec 30, 2022 | 29.73M | -91.24% |
| Dec 31, 2021 | 339.54M | 159.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 670.72B |
| Johnson & Johnson | 373.90B |
| AbbVie | 330.30B |
| Novo Nordisk | 323.14B |
| UnitedHealth Group | 276.42B |
| Abbott Laboratories | 232.39B |
| Novartis AG | 228.01B |
| AstraZeneca | 222.18B |